Bharat Biotech intranasal COVID vaccine approved by Centre, to be available on CO-WIN
The central government has approved the use of Bharat Biotech's nasal Covid vaccine iNCOVACC to be included in the country's vaccination programme as a booster dose for those above 18 years of age.The Union Health Ministry said that those who have taken Covishield and Covaxin can take the nasal vaccine as a heterologous booster dose.For more details, check out the link given below:Centre Nod...
The central government has approved the use of Bharat Biotech's nasal Covid vaccine iNCOVACC to be included in the country's vaccination programme as a booster dose for those above 18 years of age.
The Union Health Ministry said that those who have taken Covishield and Covaxin can take the nasal vaccine as a heterologous booster dose.
For more details, check out the link given below:
Centre Nod To Bharat Biotech Nasal COVID Vaccine INCOVACC, To Be Availabile In Private Hospitals
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd